Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed) | PAR 22 262

Opportunity Information: Apply for PAR 22 262

The National Institutes of Health (NIH) is offering a Research Conference Grant (R13) opportunity titled "Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)" under funding opportunity number PAR-22-262 (CFDA 93.351). The purpose of this grant is to support an annual, intensive workshop, conference, or meeting specifically designed for early stage HIV/AIDS investigators who use nonhuman primate (NHP) models and need practical, field-relevant guidance on translating NHP-based preclinical findings into human clinical research pathways. Although the event is meant to strengthen the pipeline toward clinical trials, the grant itself is explicitly not for conducting clinical trials.

The core goal of the supported meeting is career and research development for early stage researchers working at the NHP-to-human translation interface. The agenda is expected to help participants design and interpret preclinical studies that can credibly inform future clinical trials aimed at reducing HIV incidence and improving outcomes. Topics highlighted in the announcement include vaccine development and testing, advancing next-generation HIV therapies (including potential cure strategies), addressing HIV-associated coinfections, comorbidities, and complications, and improving infection prevention approaches. In addition to scientific translation, the FOA emphasizes professional skills that are often decisive for early career success, such as networking, grantsmanship, and planning goal- and milestone-driven projects that can move from concept to publishable and fundable work.

Beyond the major translational themes, the conference content is also expected to tackle practical considerations that affect how well NHP findings generalize to humans. This includes statistical issues, host genetics considerations, and concrete methods for translating NHP study outcomes into human trial design decisions. Another explicit aim is to help researchers build or refine NHP research programs so that they better mirror clinical observations and patterns seen in people living with HIV/AIDS, strengthening the relevance of NHP models for real-world clinical questions.

A wide range of domestic organizations may apply. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status; for-profit organizations other than small businesses; small businesses; public housing authorities/Indian housing authorities; and tribal governments or tribal organizations (including both federally recognized tribal governments and other than federally recognized tribal organizations). The FOA also calls out several additional eligible categories, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal government agencies.

At the same time, the eligibility rules are strict regarding foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed. In practical terms, the applicant organization and supported activities need to remain fully domestic under NIH definitions.

Funding details provided in the source indicate an award ceiling of $75,000. The original closing date listed is 2024-01-07, and the opportunity was created on 2023-01-31. Overall, this FOA is best understood as support for a recurring, structured, skill-building convening that helps early stage HIV/AIDS researchers using NHP models improve the rigor, relevance, and translational readiness of their work while also strengthening their professional networks and competitiveness for future research funding.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.351.
• This funding opportunity was created on 2023-01-31.
• Applicants must submit their applications by 2024-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $75,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 22 262

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: